CEL Book Value Per Share from 2010 to 2024

CVM Stock

USD 0.69 0.05 6.76%

CEL SCI Book Value Per Share yearly trend continues to be very stable with very little volatility. Book Value Per Share is likely to drop to 0.32. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of CEL SCI Corp according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

0.34

Current Value

0.32

Quarterly Volatility

4.39114376

Credit Downgrade

Yuan Drop

Covid

Check CEL SCI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CEL SCI's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 815.6 K or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 717, Dividend Yield of 0.0025 or PTB Ratio of 3.6. CEL financial statements analysis is a perfect complement when working with CEL SCI Valuation or Volatility modules.

Check out the analysis of CEL SCI Correlation against competitors.

Latest CEL SCI's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of CEL SCI Corp over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. CEL SCI's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CEL SCI's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.16 X

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

CEL Book Value Per Share Regression Statistics

	Arithmetic Mean	0.37
	Geometric Mean	0.51
	Coefficient Of Variation	1,175
	Mean Deviation	2.32
	Median	0.32
	Standard Deviation	4.39
	Sample Variance	19.28
	Range	19.9078
	R-Value	0.08
	Mean Square Error	20.62
	R-Squared	0.01
	Significance	0.77
	Slope	0.08
	Total Sum of Squares	269.95

CEL Book Value Per Share History

	2024	0.32
	2023	0.34
	2022	0.3
	2021	0.75
	2020	1.39
	2019	0.54
	2018	0.16

Other Fundumenentals of CEL SCI Corp

Tangible Book Value Per Share

CEL SCI Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Net Receivables	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.89	-0.48	-0.76	0.52	0.91	0.59	-0.32	-0.07	-0.45	0.45	-0.27	0.61	0.73	0.62	0.8	0.77	-0.12	0.52	-0.33	0.89	0.95	0.94	0.66
Total Stockholder Equity	0.89		-0.68	-0.5	0.08	0.92	0.53	-0.15	-0.39	-0.32	0.63	-0.17	0.28	0.65	0.32	0.84	0.63	-0.32	0.18	-0.36	0.85	0.94	0.93	0.59
Net Debt	-0.48	-0.68		-0.07	0.19	-0.76	-0.18	-0.37	0.34	-0.21	-0.63	-0.08	0.23	-0.07	0.34	-0.34	-0.04	0.07	0.1	0.07	-0.32	-0.54	-0.62	0.04
Retained Earnings	-0.76	-0.5	-0.07		-0.69	-0.5	-0.68	0.59	-0.1	0.79	0.13	0.21	-0.68	-0.75	-0.78	-0.61	-0.88	-0.06	-0.71	0.15	-0.75	-0.63	-0.56	-0.78
Total Liab	0.52	0.08	0.19	-0.69		0.3	0.29	-0.45	0.63	-0.31	-0.19	-0.28	0.79	0.28	0.72	0.09	0.52	0.34	0.79	-0.01	0.35	0.28	0.33	0.3
Total Current Assets	0.91	0.92	-0.76	-0.5	0.3		0.43	-0.08	-0.16	-0.16	0.63	-0.12	0.32	0.49	0.34	0.67	0.54	-0.06	0.37	-0.16	0.74	0.9	0.95	0.39
Short Term Debt	0.59	0.53	-0.18	-0.68	0.29	0.43		-0.59	-0.02	-0.74	-0.12	-0.35	0.31	0.73	0.39	0.56	0.75	-0.2	0.36	-0.2	0.64	0.57	0.47	0.68
Intangible Assets	-0.32	-0.15	-0.37	0.59	-0.45	-0.08	-0.59		-0.37	0.62	0.06	0.5	-0.58	-0.51	-0.65	-0.34	-0.72	0.08	-0.54	0.01	-0.52	-0.29	-0.18	-0.61
Accounts Payable	-0.07	-0.39	0.34	-0.1	0.63	-0.16	-0.02	-0.37		0.15	-0.24	-0.23	0.34	-0.3	0.22	-0.46	-0.06	0.28	0.42	0.29	-0.23	-0.27	-0.21	-0.29
Net Receivables	-0.45	-0.32	-0.21	0.79	-0.31	-0.16	-0.74	0.62	0.15		0.3	0.14	-0.48	-0.8	-0.52	-0.62	-0.75	0.07	-0.36	0.25	-0.62	-0.43	-0.24	-0.83
Short Term Investments	0.45	0.63	-0.63	0.13	-0.19	0.63	-0.12	0.06	-0.24	0.3		-0.18	0.05	0.17	-0.01	0.49	0.11	-0.17	-0.1	-0.13	0.46	0.6	0.62	0.11
Common Stock	-0.27	-0.17	-0.08	0.21	-0.28	-0.12	-0.35	0.5	-0.23	0.14	-0.18		-0.52	-0.26	-0.38	-0.22	-0.37	0.48	-0.3	0.39	-0.31	-0.26	-0.29	-0.29
Property Plant Equipment	0.61	0.28	0.23	-0.68	0.79	0.32	0.31	-0.58	0.34	-0.48	0.05	-0.52		0.48	0.82	0.41	0.65	-0.11	0.58	-0.47	0.57	0.46	0.46	0.55
Current Deferred Revenue	0.73	0.65	-0.07	-0.75	0.28	0.49	0.73	-0.51	-0.3	-0.8	0.17	-0.26	0.48		0.62	0.91	0.84	-0.17	0.35	-0.33	0.87	0.78	0.6	0.93
Long Term Debt	0.62	0.32	0.34	-0.78	0.72	0.34	0.39	-0.65	0.22	-0.52	-0.01	-0.38	0.82	0.62		0.47	0.75	-0.01	0.69	-0.19	0.62	0.52	0.49	0.64
Net Tangible Assets	0.8	0.84	-0.34	-0.61	0.09	0.67	0.56	-0.34	-0.46	-0.62	0.49	-0.22	0.41	0.91	0.47		0.75	-0.31	0.21	-0.43	0.92	0.89	0.74	0.85
Capital Surpluse	0.77	0.63	-0.04	-0.88	0.52	0.54	0.75	-0.72	-0.06	-0.75	0.11	-0.37	0.65	0.84	0.75	0.75		-0.11	0.61	-0.26	0.9	0.73	0.65	0.92
Deferred Long Term Liab	-0.12	-0.32	0.07	-0.06	0.34	-0.06	-0.2	0.08	0.28	0.07	-0.17	0.48	-0.11	-0.17	-0.01	-0.31	-0.11		0.23	0.76	-0.16	-0.17	-0.13	-0.16
Long Term Debt Total	0.52	0.18	0.1	-0.71	0.79	0.37	0.36	-0.54	0.42	-0.36	-0.1	-0.3	0.58	0.35	0.69	0.21	0.61	0.23		0.19	0.4	0.34	0.35	0.39
Short Long Term Debt	-0.33	-0.36	0.07	0.15	-0.01	-0.16	-0.2	0.01	0.29	0.25	-0.13	0.39	-0.47	-0.33	-0.19	-0.43	-0.26	0.76	0.19		-0.34	-0.29	-0.29	-0.34
Cash And Equivalents	0.89	0.85	-0.32	-0.75	0.35	0.74	0.64	-0.52	-0.23	-0.62	0.46	-0.31	0.57	0.87	0.62	0.92	0.9	-0.16	0.4	-0.34		0.91	0.84	0.88
Net Invested Capital	0.95	0.94	-0.54	-0.63	0.28	0.9	0.57	-0.29	-0.27	-0.43	0.6	-0.26	0.46	0.78	0.52	0.89	0.73	-0.17	0.34	-0.29	0.91		0.95	0.69
Net Working Capital	0.94	0.93	-0.62	-0.56	0.33	0.95	0.47	-0.18	-0.21	-0.24	0.62	-0.29	0.46	0.6	0.49	0.74	0.65	-0.13	0.35	-0.29	0.84	0.95		0.54
Capital Stock	0.66	0.59	0.04	-0.78	0.3	0.39	0.68	-0.61	-0.29	-0.83	0.11	-0.29	0.55	0.93	0.64	0.85	0.92	-0.16	0.39	-0.34	0.88	0.69	0.54

Click cells to compare fundamentals

About CEL SCI Financial Statements

CEL SCI investors utilize fundamental indicators, such as Book Value Per Share, to predict how CEL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	0.34	0.32
Tangible Book Value Per Share	0.34	0.32

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:

How To Invest In CEL

Details

Is CEL Stock a good investment?

Details

What is CEL SCI's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of CEL SCI Correlation against competitors.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.52)

Revenue Per Share

0.001

Quarterly Revenue Growth

(0.63)

Return On Assets

(0.61)

Return On Equity

(2.50)

The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CEL Book Value Per Share from 2010 to 2024

Latest CEL SCI's Book Value Per Share Growth Pattern

CEL Book Value Per Share Regression Statistics

CEL Book Value Per Share History

Other Fundumenentals of CEL SCI Corp

CEL SCI Book Value Per Share component correlations

About CEL SCI Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY